Industry
PT Equilab International
Total Trials
6
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 1
2(33.3%)
N/A
2(33.3%)
Phase 2
1(16.7%)
Phase 3
1(16.7%)
6Total
Phase 1(2)
N/A(2)
Phase 2(1)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT07420491Phase 3Completed
The Efficacy and Safety of Reconyl in Acute Cough Treatment
Role: collaborator
NCT06817811Phase 1Completed
Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet
Role: collaborator
NCT06127225Phase 2Completed
Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)
Role: collaborator
NCT06558058Phase 1Completed
Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets
Role: collaborator
NCT06127212Not ApplicableCompleted
Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets
Role: collaborator
NCT03422575Not ApplicableCompleted
Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets
Role: collaborator
All 6 trials loaded